These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Developmental syndromes: growth hormone deficiency and treatment. Mazzanti L, Tamburrino F, Bergamaschi R, Scarano E, Montanari F, Torella M, Ballarini E, Cicognani A. Endocr Dev; 2009; 14():114-34. PubMed ID: 19293579 [Abstract] [Full Text] [Related]
4. Idiopathic short stature: decision making in growth hormone use. Maheshwari N, Uli NK, Narasimhan S, Cuttler L. Indian J Pediatr; 2012 Feb; 79(2):238-43. PubMed ID: 22094625 [Abstract] [Full Text] [Related]
5. Clinical and humanistic aspects of growth hormone deficiency and growth-related disorders. Rogol AD. Am J Manag Care; 2011 Dec; 17 Suppl 18():eS4-10. PubMed ID: 22590765 [Abstract] [Full Text] [Related]
6. Controversies in the definition and treatment of idiopathic short stature (ISS). Pedicelli S, Peschiaroli E, Violi E, Cianfarani S. J Clin Res Pediatr Endocrinol; 2009 Dec; 1(3):105-15. PubMed ID: 21274395 [Abstract] [Full Text] [Related]
7. The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature. Kucharska A, Witkowska-Sędek E, Erazmus M, Artemniak-Wojtowicz D, Krajewska M, Pyrżak B. Int J Mol Sci; 2024 Sep 22; 25(18):. PubMed ID: 39337654 [Abstract] [Full Text] [Related]
8. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature. Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG). Clin Endocrinol (Oxf); 2012 Jul 22; 77(1):62-71. PubMed ID: 21950731 [Abstract] [Full Text] [Related]
9. Current indications for growth hormone therapy for children and adolescents. Richmond E, Rogol AD. Endocr Dev; 2010 Jul 22; 18():92-108. PubMed ID: 20523020 [Abstract] [Full Text] [Related]
13. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature. Liu HJ, Wang LH, Chen L. Adv Ther; 2019 Sep 22; 36(9):2374-2383. PubMed ID: 31301056 [Abstract] [Full Text] [Related]
14. Metabolic benefits of growth hormone therapy in idiopathic short stature. Dahlgren J. Horm Res Paediatr; 2011 Sep 22; 76 Suppl 3():56-8. PubMed ID: 21912170 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy in children: The use of growth hormone and IGF-I. Pfäffle R. Best Pract Res Clin Endocrinol Metab; 2015 Jun 22; 29(3):339-52. PubMed ID: 26051295 [Abstract] [Full Text] [Related]
16. Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program. Sävendahl L, Polak M, Backeljauw P, Blair J, Miller BS, Rohrer TR, Pietropoli A, Ostrow V, Ross J. J Clin Endocrinol Metab; 2019 Oct 01; 104(10):4730-4742. PubMed ID: 31305924 [Abstract] [Full Text] [Related]
18. The effect of growth hormone treatment on height in children with idiopathic short stature. Jeong HR, Shim YS, Lee HS, Hwang JS. J Pediatr Endocrinol Metab; 2014 Jul 01; 27(7-8):629-33. PubMed ID: 24810558 [Abstract] [Full Text] [Related]